Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.